Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients

Pyoderma gangrenosum (PG) is a rarely diagnosed ulcerative neutrophilic dermatosis with unknown origin that has been poorly characterized in clinical studies so far. Consequently there have been significant discussions about its associated factors and comorbidities. The aim of our multicenter study...

Full description

Saved in:
Bibliographic Details
Published inOrphanet journal of rare diseases Vol. 8; no. 1; p. 136
Main Authors Al Ghazal, Philipp, Herberger, Katharina, Schaller, Jörg, Strölin, Anke, Hoff, Norman-Philipp, Goerge, Tobias, Roth, Hannelore, Rabe, Eberhard, Karrer, Sigrid, Renner, Regina, Maschke, Jan, Horn, Thomas, Hepp, Julia, Eming, Sabine, Wollina, Uwe, Zutt, Markus, Sick, Isabell, Splieth, Benno, Dill, Dorothea, Klode, Joachim, Dissemond, Joachim
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 08.09.2013
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pyoderma gangrenosum (PG) is a rarely diagnosed ulcerative neutrophilic dermatosis with unknown origin that has been poorly characterized in clinical studies so far. Consequently there have been significant discussions about its associated factors and comorbidities. The aim of our multicenter study was to analyze current data from patients in dermatologic wound care centers in Germany in order to describe associated factors and comorbidities in patients with PG. Retrospective clinical investigation of patients with PG from dermatologic wound care centers in Germany. We received data from 259 patients with PG from 20 different dermatologic wound care centers in Germany. Of these 142 (54.8%) patients were female, 117 (45.2%) were male; with an age range of 21 to 95 years, and a mean of 58 years. In our patient population we found 45.6% with anemia, 44.8% with endocrine diseases, 12.4% with internal malignancies, 9.3% with chronic inflammatory bowel diseases and 4.3% with elevated creatinine levels. Moreover 25.5% of all patients had a diabetes mellitus with some aspects of potential association with the metabolic syndrome. Our study describes one of the world's largest populations with PG. Beside the well-known association with chronic bowel diseases and neoplasms, a potentially relevant new aspect is an association with endocrine diseases, in particular the metabolic syndrome, thyroid dysfunctions and renal disorders. Our findings represent clinically relevant new aspects. This may help to describe the patients' characteristics and help to understand the underlying pathophysiology in these often misdiagnosed patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1750-1172
1750-1172
DOI:10.1186/1750-1172-8-136